Surgical, interventional, and device innovations in the management of hypertension

Sibu P Saha1, Khaled M Ziada2, Thomas F Whayne2

  • 1Division of Cardiothoracic Surgery, Gill Heart Institute, University of Kentucky, Lexington, Kentucky.

Insights

Hypertension is a growing global health issue. Newer treatments like renal artery denervation and baroreflex activation therapy offer significant benefits for medication-resistant hypertension patients.

Area of Science:

  • Cardiovascular medicine
  • Interventional cardiology
  • Nephrology

Background:

  • Hypertension prevalence is rising globally, posing a significant health burden.
  • Medication-resistant hypertension presents challenges in patient management.
  • Advanced treatment options are increasingly necessary for complex cases.

Purpose of the Study:

  • To review the evolution and current status of advanced treatment modalities for hypertension.
  • To highlight newer interventional and device-based therapies for resistant hypertension.
  • To discuss the evidence supporting novel approaches to hypertension management.

Main Methods:

  • Review of current literature on interventional and device-based therapies for hypertension.
  • Analysis of the progression from traditional surgical methods to contemporary techniques.
  • Evaluation of evidence for angioplasty with stenting, renal artery denervation, and baroreflex activation therapy.

Main Results:

  • Traditional surgical interventions for hypertension are largely obsolete.
  • Modern techniques like renal artery denervation and baroreflex activation therapy show increasing evidence of significant benefit.
  • Percutaneous interventions and device management represent the forefront of resistant hypertension treatment.

Conclusions:

  • The management of resistant hypertension has evolved towards less invasive, technologically advanced interventions.
  • Renal artery denervation and baroreflex activation therapy are promising options for difficult-to-treat hypertension.
  • Continued research and clinical application of these newer techniques are crucial for improving patient outcomes.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
605
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
610
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
579
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
926
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
662